Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
morbid obesity
 
Major Surgical or Invasive Procedure:
___ laparascopic sleeve gastrectomy

 
History of Present Illness:
___ woman with longstanding morbid obesity refractory to 
attempts at weight loss by nonoperative means.  Her weight with 
us as of today is 226.7 pounds.  Given her height, this 
translates to a body mass index of 41.8 kg/m2. 
Her previous unsuccessful attempts at weight loss have included 
Weight Watchers, over-the-counter pancrease and lipase inhibitor 
___, self-initiated diet, exercise.  Unfortunately, these have 
been all to no avail, ultimately.

She has been considering weight loss surgery for a number of
years.  She has family members who have had gastric bypass.  She
feels this is too extreme.  She does not like the idea of the 
lap
band due to the foreign body nature.  She prefers a sleeve
gastrectomy.

 
Past Medical History:
1.  Obstructive sleep apnea.
2.  Allergic rhinitis.
3.  Asthma.  No intubations, no prednisone.
4.  History of vitamin D deficiency.
5.  History of iron deficiency.
6.  Hyperlipidemia, mild.
7.  Mild Eczema.
8.  Dysmenorrhea.

Past Surgical History:
1.  Tonsillectomy ___.
2.  Breast reduction, ___.
 
Social History:
___
Family History:
Mother with obesity status post gastric bypass,
grandfather with diabetes, sister with obesity, brother with
obesity, status post Roux-en-Y gastric bypass.

 
Physical Exam:
VS: 98.2 130/80 81 18 98RA 
GEN: AA&O x 3, NAD, calm, cooperative.  
HEENT: EOMI, PERRL.  
CHEST: Clear to auscultation bilaterally  
ABDOMEN:(+) BS x 4 quadrants, soft, tender near incision sites
 incision sites are c/d/i covered with steri-strips  
EXTREMITIES: Warm, well perfused, pulses palpable
 
Pertinent Results:
Labs
___ 11:10AM BLOOD Hct-45.7*
___ 04:42AM BLOOD Hct-37.7
___ 01:07PM BLOOD Hct-36.5

Imaging
___ UGIS
FINDINGS: 
Water-soluble contrast (Optiray) was administered followed by 
thin consistency
barium with the patient upright.
Barium passed freely through the esophagus into the stomach and 
then into the
proximal small bowel. There is no evidence of leak or 
obstruction.
 
IMPRESSION: 
No evidence of leak or obstruction.

 
Brief Hospital Course:
The patient presented to pre-op on ___. Pt was evaluated by 
anaesthesia.  
The patient was taken to the operating room for a laparoscopic 
sleeve gastrectomy for obesity. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation.  

Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet.  
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
GI/GU/FEN: The patient was initially kept NPO. On POD 1 the 
patient had an upper GI series which revealed no leak. As a 
result, the patient was started on a stage 1 bariatric diet, 
which the patient tolerated well. Subsequently, the patient was 
advanced to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.  
HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
Prophylaxis: The patient received subcutaneous heparin and 
venodyne boots were used during this stay and was encouraged to 
get up and ambulate as early as possible.  

At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Desonide 0.05% Cream 1 Appl TP DAILY 
2. Hydrocortisone Cream 1% 1 Appl TP DAILY 
3. Multivitamins 1 TAB PO DAILY 
4. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID 
5. Cetirizine Dose is Unknown  PO DAILY 
6. albuterol sulfate 90 mcg/actuation inhalation QID:PRN asthma 

 
Discharge Medications:
1. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID 
2. albuterol sulfate 90 mcg/actuation inhalation QID:PRN asthma 
3. Cetirizine 0 unit PO DAILY 
please crush before taking 
4. Desonide 0.05% Cream 1 Appl TP DAILY 
5. Hydrocortisone Cream 1% 1 Appl TP DAILY 
6. Multivitamins 1 TAB PO DAILY 
please crush before taking 
7. Docusate Sodium (Liquid) 100 mg PO BID 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day 
Refills:*0
8. Ranitidine (Liquid) 150 mg PO BID 
RX *ranitidine HCl 15 mg/mL 10 ml by mouth twice a day 
Refills:*0
9. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
please crush before taking 
RX *oxycodone 5 mg ___ tablet(s) by mouth every four hours Disp 
#*45 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Please call your surgeon or return to the emergency department 
if you develop a fever greater than 101.5, chest pain, shortness 
of breath, severe abdominal pain, pain unrelieved by your pain 
medication, severe nausea or vomiting, severe abdominal 
bloating, inability to eat or drink, foul smelling or colorful 
drainage from your incisions, redness or swelling around your 
incisions, or any other symptoms which are concerning to you.  
Diet: Stay on Stage III diet until your follow up appointment. 
Do not self advance diet, do not drink out of a straw or chew 
gum  
Resume your home medications, CRUSH ALL PILLS. 
 
You will be starting some new medications:  
1. You are being discharged on medications to treat the pain  
from your operation. These medications will make you drowsy and  

impair your ability to drive a motor vehicle or operate  
machinery safely. You MUST refrain from such activities while  
taking these medications.  
2. You should begin taking a chewable complete multivitamin with 
 
minerals. No gummy vitamins.  
3. You will be taking Zantac liquid ___ mg twice daily for one  
month. This medicine prevents gastric reflux.  
4. You should take a stool softener, Colace, twice daily for  
constipation as needed, or until you resume a normal bowel  
pattern.  
5. You must not use NSAIDS (non-steroidal anti-inflammatory  
drugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and  
Naproxen. These agents will cause bleeding and ulcers in your  
digestive system. 
 
Activity:  
No heavy lifting of items ___ pounds for 6 weeks. You may  
resume moderate exercise at your discretion, no abdominal  
exercises. 
 
Wound Care:  
You may shower, no tub baths or swimming.  
If there is clear drainage from your incisions, cover with  
clean, dry gauze.
  
Your steri-strips will fall off on their own. Please remove any  

remaining strips ___ days after surgery.  
Please call the doctor if you have increased pain, swelling,  
redness, or drainage from the incision sites.  
 
Followup Instructions:
___